Conformationally locked nucleoside analogs as antiherpetic agents
US5840728A · kind A · utility
11Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 7, 1997 |
| Grant date | Nov 24, 1998 |
| Priority date | — |
| Expiry date | Aug 7, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treatment of herpes virus infection by administering an effective virus-inhibiting amount of a cyclopropanated carbocyclic 2'-deoxynucleoside to an individual in need thereof. The nucleoside analogs are effective against herpes simplex virus types 1 and 2; Epstein-Barr Virus and human cytomegalovirus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.